Skip to main content

EL ESTUDIO DE LA VIA DE SEÑALIZACION WNT/BETA-CATENINA EN LA REGULACION DE LA REPROGRAMACION Y REGENERACION DE TEJIDOS

BES-2015-075805

•
Funding agency name Ministerio de Ciencia e Innovación
Funding agency acronym MICINN
Program Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprogram Subprograma Estatal de Formación
Call Contratos Predoctorales
Call year 2015
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Dirección General de Investigación Científica y Técnica
Beneficiary centre FUNDACIO CENTRE DE REGULACIO GENOMICA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The chemokine receptors Ccr5 and Cxcr6 enhance migration of mesenchymal stem cells into the degenerating retina

  • Pesaresi, Martina, 1991-
  • Bonilla-Pons, Sergi A.
  • Sebastián Pérez, Rubén
  • Di Vicino, Umberto
  • Alcoverro-Bertran, Marc
  • Michael, Ralph
  • Cosma, Maria Pia
Cell therapy approaches hold great potential for treating retinopathies, which are currently incurable. This study addresses the problem of inadequate migration and integration of transplanted cells into the host retina. To this end, we have identified the chemokines that were most upregulated during retinal degeneration and that could chemoattract mesenchymal stem cells (MSCs). The results were observed using a pharmacological model of ganglion/amacrine cell degeneration and a genetic model of retinitis pigmentosa, from both mice and human retinae. Remarkably, MSCs overexpressing Ccr5 and Cxcr6, which are receptors bound by a subset of the identified chemokines, displayed improved migration after transplantation in the degenerating retina. They also led to enhanced rescue of cell death and to preservation of electrophysiological function. Overall, we show that chemokines released from the degenerating retinae can drive migration of transplanted stem cells, and that overexpression of chemokine receptors can improve cell therapy-based regenerative approaches., This work was supported by Velux Stiftung (976 a to M.P.C.), La Caixa Health (HR17-00231), the Ministerio de Ciencia e Innovación, (BFU2017-86760-P to M.P.C.) (AEI/FEDER, UE), the AGAUR grant from Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya, (2017 SGR 689 to M.P.C.), the subprograma estatal de Formación del Ministerio de Economía y Competitividad ref. BES-2015-075802 (to M.P.) and ref. BES-2015-075805 (to S.A.B.-P.), the Secretaria d'Universitats i Recerca del Departament d'Empresa i Coneixement de la Generalitat de Catalunya ref. 2018FI_B_00637 (to R.S.-P.), and the co‐finance of Fondo Social Europeo (FSE to R.S.-P.). We acknowledge support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme / Generalitat de Catalunya
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The chemokine receptors Ccr5 and Cxcr6 enhance migration of mesenchymal stem cells into the degenerating retina

  • Pesaresi, Martina, 1991-
  • Bonilla-Pons, Sergi A.
  • Sebastián Pérez, Rubén
  • Di Vicino, Umberto
  • Alcoverro-Bertran, Marc
  • Michael, Ralph
  • Cosma, Maria Pia
Cell therapy approaches hold great potential for treating retinopathies, which are currently incurable. This study addresses the problem of inadequate migration and integration of transplanted cells into the host retina. To this end, we have identified the chemokines that were most upregulated during retinal degeneration and that could chemoattract mesenchymal stem cells (MSCs). The results were observed using a pharmacological model of ganglion/amacrine cell degeneration and a genetic model of retinitis pigmentosa, from both mice and human retinae. Remarkably, MSCs overexpressing Ccr5 and Cxcr6, which are receptors bound by a subset of the identified chemokines, displayed improved migration after transplantation in the degenerating retina. They also led to enhanced rescue of cell death and to preservation of electrophysiological function. Overall, we show that chemokines released from the degenerating retinae can drive migration of transplanted stem cells, and that overexpression of chemokine receptors can improve cell therapy-based regenerative approaches., This work was supported by Velux Stiftung (976 a to M.P.C.), La Caixa Health (HR17-00231), the Ministerio de Ciencia e Innovación, (BFU2017-86760-P to M.P.C.) (AEI/FEDER, UE), the AGAUR grant from Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya, (2017 SGR 689 to M.P.C.), the subprograma estatal de Formación del Ministerio de Economía y Competitividad ref. BES-2015-075802 (to M.P.) and ref. BES-2015-075805 (to S.A.B.-P.), the Secretaria d'Universitats i Recerca del Departament d'Empresa i Coneixement de la Generalitat de Catalunya ref. 2018FI_B_00637 (to R.S.-P.), and the co‐finance of Fondo Social Europeo (FSE to R.S.-P.). We acknowledge support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme / Generalitat de Catalunya